Insource specialist testing without increasing your cost base.

How did Spectrum Health determine that ramping up a new test offering was feasible immediately?


spec.jpg


 
result-capital.jpg
result-capital-sub.jpg
 
 

Context: The need for new testing capability

The Spectrum Health Advanced Technology Laboratory (ATL) was performing a feasibility study to establish a Human Leukocyte Antigen (HLA) Typing capability within the current molecular laboratory. The laboratory needed to determine whether it could bring on HLA testing using existing staff.

Approach:  Evaluating the impact

Resource data, workforce utilization analytics, the HLA process design and expected service performance were examined. Considering increasing Next-Generation Sequencing (NGS) volumes and additional protocols, it was found that current staff would be sufficient to bring on the new test. The original assumption was that a dedicated HLA laboratory would be required from the outset.


Kim-C.jpg

“With the Performance Assurance Report and the PinpointBPS® modeling, we were able to determine that we could utilize existing staff to perform testing for the HLA laboratory start up.”

— Kim Collison, Director of Laboratory Services, Advanced Technology Laboratories, Spectrum Health, Grand Rapids, Michigan


Results: Immediate realization of the opportunity

  • Unnecessary startup capital investment was avoided.

  • Opportunity to add new testing capability could be immediately realized.

  • Additional staff would only be required down the line, if operational volumes increased. 

Get the Spectrum Health Case Study
Description
Salutation*
First Name*
Last Name*
Position*
Email*
Company*
Phone*
Country*
City*
Captcha
Reload
 
Logo-Spectrum.jpg
 
 
Logo-LTS.jpg
 
 
Logo-Pinpoint.jpg